Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News 4Front Ventures Corp FFNTF


Primary Symbol: C.FFNT

Healthcare
4Front Ventures Corp. is a vertically integrated, multi-state cannabis operator and retailer with operations in Illinois and Massachusetts and facilities in Washington. The Company manufactures and distributes a portfolio of over 25 cannabis brands including Mission, the Hunt, Marmas, Crystal Clear, Legends, and Island. The Company distributes its products through third party retail outlets, as... see more

Recent & Breaking News (CSE:FFNT)

4Front Ventures Reports Third Quarter 2024 Results

PR Newswire 8 days ago

4Front Ventures to Report Third Quarter 2024 Financial Results on November 14, 2024

PR Newswire November 7, 2024

4Front Ventures Corp. Announces Official Ribbon Cutting of Its 250,000 Sq. Ft. Cultivation and Production Facility in Illinois, Now Operational and Serving Mission Dispensaries and the State of Illinois

PR Newswire November 4, 2024

4Front Welcomes New Leadership as CFO Peter Kampian Transitions Out of Role

PR Newswire October 29, 2024

4Front Ventures Retains Canaccord Genuity to Optimize Capital Structure and Announces Amendment of Credit Facility and Issuance of Restricted Stock Units

PR Newswire September 25, 2024

4Front Ventures Reports Second Quarter 2024 Results

PR Newswire August 14, 2024

4Front Ventures Expands Product Line Up in Illinois and Massachusetts with Smoke Breaks

PR Newswire August 7, 2024

4Front Ventures to Report Second Quarter 2024 Financial Results on August 14, 2024

PR Newswire August 7, 2024

4Front Ventures Announces Withdrawal of Brokered Offering and Appointment of New Board Chair

PR Newswire July 5, 2024

4Front Ventures Announces Brokered Offering of Up to C$5,000,100 of Units

PR Newswire June 26, 2024

4Front Ventures Announces Opening of New Mission Dispensary in Norridge, Illinois

PR Newswire May 23, 2024

4Front Ventures Reports First Quarter 2024 Results

PR Newswire May 17, 2024

4Front Ventures to Report First Quarter 2024 Financial Results on May 17, 2024

PR Newswire May 14, 2024

4Front Ventures Announces Issuance of Securities to Consultants, Directors, and Officers

PR Newswire April 24, 2024

4Front Ventures Reports Fourth Quarter and Full Year 2023 Financial Results

PR Newswire April 15, 2024

4Front Ventures to Report Fourth Quarter and Full Year 2023 Financial Results on April 15, 2024

PR Newswire March 27, 2024

4Front Ventures Provides Progress Report on Norridge Opening and Matteson Facility Updates and Announces Launch of Crystal Clear Blast in Massachusetts and Illinois

PR Newswire March 21, 2024

4Front Ventures Unveils Mission: A Signature Cannabis Experience

PR Newswire February 20, 2024

4Front Furthers Expansion Strategy in Illinois

PR Newswire February 5, 2024

4Front Ventures Corp. Closes Transformational Senior Secured Debt to Equity Conversion

PR Newswire January 31, 2024